Details of the Drug

General Information of Drug (ID: DMS1PFA)

Drug Name

SB2

Synonyms

Antimony; 7440-36-0; Stibium metallicum; Antimony, metallic; UNII-9IT35J3UV3; Antymonowodor [Polish]; UNII-0VKZ97K3UB; 0VKZ97K3UB; Antimonwasserstoffes [German]; HSDB 785; 9IT35J3UV3; UN2676; Antymon; Antimonio; Antimoine; Antimony powder; MFCD00011211; Antimonyl citrate; Antimony, ion(Sb2+); Sb2+; stibanylidyne; Antimonide; Antymonowodor; Antimon; antimony atom; Antimony, citric acid complexes; antimony(0); Antimonwasserstoffes; EINECS 270-130-2; ANTIMONOUS HYDRIDE; ACMC-1BKT5; 51Sb; EC 231-146-5; AC1NS5Q0; Sb(0); ANT

Indication

Disease Entry	ICD 11	Status	REF
Plaque psoriasis	EA90.0	Phase 3	[1]
Ankylosing spondylitis	FA92.0	Application submitted	[1]
Crohn disease	DD70	Application submitted	[1]
Psoriatic arthritis	FA21	Application submitted	[1]
Ulcerative colitis	DD71	Application submitted	[1]
------------------------------------------------------------------------------------

Structure

3D MOL

2D MOL

Chemical Identifiers

Formula: Sb
Canonical SMILES: [Sb]
InChI: 1S/Sb
InChIKey: WATWJIUSRGPENY-UHFFFAOYSA-N

Cross-matching ID

PubChem CID: 5354495
ChEBI ID: CHEBI:30304
CAS Number: 7440-36-0
UNII: 9IT35J3UV3
DrugBank ID: DB13110
TTD ID: D0CU1T

Repurposed Drugs (RPD)

Click to Jump to the Detailed RPD Information of This Drug

References

1	Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)